ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "macrophages"

  • Abstract Number: 1793 • ACR Convergence 2025

    Sex-associated changes to synovial macrophages in the aging joint

    Matthew Dapas1, Erica De Jong2, Yidan Wang3, Cally Mills3, Samuel Dowling4, Tyler Therron5, Carla Marie Cuda3, Dawn Bowdish6 and Deborah Rachelle Winter7, 1Northwestern University Feinberg School of Medicine, Chicago, IL, 2McMaster Immunology Research Centre, Hamilton, ON, Canada, 3Northwestern University, Chicago, IL, 4Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, 5Northwestern Feinberg School of Medicine, Chicago, IL, 6McMaster University, Hamilton, ON, Canada, 7Northwestern University, Skokie, IL

    Background/Purpose: Macrophages are found in nearly every tissue of the body where they maintain homeostasis and drive healthy immune response. However, macrophages are dysregulated with…
  • Abstract Number: 0921 • ACR Convergence 2025

    Fibrinogen Co-Modified with Malondialdehyde-Acetaldehyde and Citrulline Promotes Pro-Inflammatory Macrophage Differentiation Through p38 and NF-κB Signaling

    Hannah Johnson1, Wenxian Zhou2, Michael Duryee1, Carlos Hunter1, Geoffrey Thiele1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Medical Center, Bellevue, NE

    Background/Purpose: Citrulline (CIT) and malondialdehyde-acetaldehyde (MAA) co-adduct native proteins in RA tissues to create a dual pro-inflammatory and pro-fibrotic milieu. Our previous work demonstrated that…
  • Abstract Number: 1787 • ACR Convergence 2025

    Spatial and Quantitative Semiautomated Image Analysis of Synovial Biopsies Studied Using a Novel High-Plex Immunofluorescence Platform

    Estefania Quesada-Masachs1, Luis Peñaranda Bolaño1, Aakriti Arora2, Jessica Murillo-Saich3, Edward Lo4, Tad George4, Daniel Tanoeihusada4, Sara McArdle5 and Monica Guma6, 1University of Miami, Miami, FL, 2University of Miami / Jackson Memorial Hospital, Miami, FL, 3University of California, San Diego, San Diego, CA, 4RareCyte, Seattle, WA, 5La Jolla Institute for Immunology, La Jolla, CA, 6University of California San Diego, San Diego, CA

    Background/Purpose: Although not part of the formal ACR criteria for RA, PsA, or OA, synovial pathology can be a helpful tool in clinical practice. Histopathologic…
  • Abstract Number: 0908 • ACR Convergence 2025

    E-602 (Efgitasialase alfa) Enhances Memory B Cell Depletion and Reduces Profibrotic Macrophages via Desialylation in Autoimmune Disease

    Hrishikesh Mehta1, Vijayashree Mysore1, Chih-Hsing Chou1, Lizhi Cao1, Rui Liu2, Tianrui Fan2, Jijun Yuan2, James Broderick1 and Li Peng1, 1Palleon Pharmaceuticals, Waltham, MA, 2Shanghai Henlius Biotech, Shanghai, China (People's Republic)

    Background/Purpose: Abnormal cell surface glycosylation has been observed in various autoimmune diseases, including systemic lupus erythematosus (SLE) and membranous nephropathy. Among these glycan modifications, sialoglycans…
  • Abstract Number: 1779 • ACR Convergence 2025

    Citrullinated and Malondialdehyde-Acetaldehyde Modified Fibrinogen Activates Macrophages and Induces Inflammatory Responses in Coronary Endothelium

    Wenxian Zhou1, Hannah Johnson2, Michael Duryee2, Engle Sharp2, Carlos Hunter2, Tate Johnson2, Mabruka Alfaidi2, Daniel Anderson3, Kishore Bidasee2, Geoffrey Thiele2 and Ted Mikuls2, 1University of Nebraska Medical Center, Bellevue, NE, 2University of Nebraska Medical Center, Omaha, NE, 30587964, Durham, NC

    Background/Purpose: Endothelial cell (EC) dysfunction is a key driver of cardiovascular (CV) complications in rheumatoid arthritis (RA), yet mechanisms underlying EC dysfunction in RA are…
  • Abstract Number: 0893 • ACR Convergence 2025

    Transcriptomic insights into GCA compared to clinically diverse controls: Inflammation, Aging, Therapeutic Targets and the role of SPP1 in the temporal artery

    Ingrid Lindquist1, Alisha Eskew2, Dongsoek Choi3, David Wilson4, Diva Salomao5, Hillary Stiefel4, Daniel Albert4, Kiana Vakil-Gilani6, Daniela Ghetie7, James Rosenbaum8 and Marcia Friedman9, 1Portland VA Medical Center, Portland, OR, 2OHSU, Portland, OR, 3OHSU, Portland, 4Casey Eye Institute OHSU, Portland, OR, 5Mayo Clinic, Rochester, MN, 6PeaceHealth, Portland, OR, 7OHSU, Lake Oswego, OR, 8Legacy Devers Eye Institute, Portland, OR, 9Immpact Bio, Beaverton, OR

    Background/Purpose: Giant cell arteritis (GCA) is the most common vasculitis in people over 50 years old and is a clinical diagnosis bolstered by non-specific inflammatory…
  • Abstract Number: 0057 • ACR Convergence 2024

    Flow Cytometry of Cells Within Induced Sputum from Individuals At-Risk for RA Reveals Relative Expansion of Small Macrophages

    Hideto Takada1, Brian Hattel2, Marie Feser3, LauraKay Moss2, Yuko Okamoto4, Mark Gillespie5, Adam Savage5, Troy Torgerson6, V. Michael Holers7, Kevin Deane8 and Kristen Demoruelle9, 1Tokyo Women's Medical University, Denver, CO, 2University of Colorado Anschutz Medical Campus, Denver, CO, 3Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 4Tokyo Women's Medical University Division of Rheumatology, Shinjyuku-ku, Tokyo, Japan, 5Allen Institute for Immunology, Seattle, WA, 6Allen Institute for Immunology, Enumclaw, WA, 7University of Colorado, Denver, CO, 8University of Colorado Denver Anschutz Medical Campus, Aurora, CO, 9University of Colorado Anschutz Medical Campus, Golden, CO

    Background/Purpose: Serum elevations of ACPA in the absence of inflammatory arthritis is a well-established risk factor for the future development of clinical RA. The lung…
  • Abstract Number: 0966 • ACR Convergence 2024

    CDDO-Me Attenuates Pro-fibrotic Activation in Macrophages and Fibroblasts in Systemic Sclerosis

    Heetaek Yang1, Chanhyuk Park2, Chen-Yu Wang3, Emily Morris4, Karen Liby5, Michael Whitfield6 and Patricia Pioli2, 1Dartmouth College, West Lebanon, NH, 2Geisel School of Medicine at Dartmouth, Lebanon, NH, 3Dartmouth College, Lebanon, NH, 4Dartmouth College, Enfield, NH, 5Department of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis, IN, 6Geisel School of Medicine at Dartmouth, Hanover, NH

    Background/Purpose: Systemic Sclerosis (SSc) is characterized by dysfunctional immune activation, oxidative stress, and fibrosis. In prior work, we have shown that SSc macrophages (MØs) have…
  • Abstract Number: 2547 • ACR Convergence 2024

    Neurophysiological Phenotypes Are Uncoupled from Toll-like Receptor-Mediated Peripheral Disease in a Mouse Model of Neuropsychiatric Symptoms of Systemic Lupus Erythematosus

    Cecilia Stumpf1, Vanessa Rodriguez1 and Carla Cuda2, 1Northwestern University, Chicago, 2Northwestern University, Chicago, IL

    Background/Purpose: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical presentations, including neuropsychiatric symptoms (NPSLE). Despite being a major cause of morbidity…
  • Abstract Number: 0061 • ACR Convergence 2024

    Comparative Transcriptional Profiling of IPF and RA-ILD Lung Tissue Demonstrates Both Overlapping and Distinct Cell-specific Signaling Pathways

    Joshua Sciurba1, Daniel Kass1, Eleanor Valenzi2, John Sembrat2, Robert Lafyatis3 and Dana Ascherman4, 1University of Pittsburgh School of Medicine, Pittsburgh, PA, 2University of Pittsburgh, Pittsburgh, PA, 3Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 4Division of Rheumatology and Clinical Immunology, University of Pittsburgh Medical Center, Pittsburgh, PA

    Background/Purpose: Transcriptional profiling represents a powerful tool for deciphering disease-relevant pathways and deriving functional biomarkers.  Given the shared demographic, genetic, and clinico-epidemiologic features between rheumatoid…
  • Abstract Number: 0972 • ACR Convergence 2024

    Downregulated Fli1 in Scleroderma Myeloid Cells Contributes to Cardiac Fibrosis via a Galectin-3/mTOR Dependent Pathway

    Fatima El adili1, Moyo Mudhibadhi2, Giovanni ligresti3, Maria Trojanowska2 and Andreea Bujor3, 1Boston Medical Center, Boston, MA, 2Boston university medical school, Boston, MA, 3Boston University, Boston, MA

    Background/Purpose: Cardiac fibrosis is a common complication in Systemic sclerosis (SSc), but the pathogenesis is largely unknown. We have previously shown that monocytes isolated from…
  • Abstract Number: 2550 • ACR Convergence 2024

    Infiltrating and Resident Macrophages in Lupus Nephritis: Scar Associated Macrophage Phagocytic Dysfunction and Fibroblast Activation

    Chirag Raparia1, Paul Hoover2, Arnon Arazi3, Nir Hacohen4 and Anne Davidson5, 1Donald and Barbara Zucker School of Medicine At Hofstra/Northwell, Shoreham, NY, 2Brigham and Women's Hospital, SWAMPSCOTT, MA, 3Feinstein Institutes for Medical Research, Melrose, MA, 4Broad Institute of MIT and Harvard, Boston, MA, 5Feinstein Institutes for Medical Research, Manhasset, NY

    Background/Purpose: Lupus nephritis (LN) is driven by a heterogeneous population of renal macrophages. We have previously reported that the renal macrophage subpopulations are similar in…
  • Abstract Number: 0062 • ACR Convergence 2024

    Pro-Fibrotic Effects of Malondialdehyde-Acetaldehyde-Adducted and/or Citrullinated Proteins on Macrophages and Human Lung Fibroblasts

    Lauren Klingemann1, Nozima Aripova1, Nigina Aripova2, Michael Duryee1, Carlos Hunter1, Jill Poole1, Bryant England1, Ted Mikuls1 and Geoffrey Thiele1, 1University of Nebraska Medical Center, Omaha, NE, 2WUSTL, St. Louis, MO

    Background/Purpose: Clinically evident rheumatoid arthritis-associated interstitial lung disease (RA-ILD) affects approximately 10-15% of patients with rheumatoid arthritis (RA) and accounts for the most overrepresented cause…
  • Abstract Number: 0973 • ACR Convergence 2024

    Mechano-transduction via MRTF-A Pathway Is Required for Cytokine Release by Scleroderma Macrophages

    Sandra Lopez Garces1, Guan Hui Tricia Lim2, Jorlin Liu3, Maahia Choudhary3, Juno Erin Vimalenthiran,3, Angela Tam1, David Abraham3, Christopher Denton4, Bahja Ahmed Abdi1 and Richard Stratton5, 1University College London, London, United Kingdom, 2Centre for Rheumatology and Connective Tissue Diseases, University College London Medical School, Royal Free Campus, London, United Kingdom, 3UCL, London, United Kingdom, 4University College London, Northwood, United Kingdom, 5UCL, London, England, United Kingdom

    Background/Purpose: In keeping with hallmark clinical evidence of stiffening and fibrotic thickening of the skin, we and others have previously demonstrated a role for the…
  • Abstract Number: 2593 • ACR Convergence 2024

    A Long-term Synovial Tissue 3D Model Incorporating Fibroblasts, Macrophages, Endothelial Cells, and Other Immune Cells Such as Innate Lymphoid Cells Enables Animal Model-Independent Rheumatoid Arthritis Research

    Miriam Bollmann1, Oskar Landberg2, Negar Ayoubzadeh2, Charlotte A. Jonsson2, Inger Gjertsson2 and Mattias Svensson2, 1University of Gothenburg, Göteborg, Sweden, 2University of Gothenburg, Gothenburg, Sweden

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease with multiple tissues contributing to its pathology, including the synovial membrane. The RA synovial membrane…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 14
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology